Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

AGM Statement

23 May 2007 11:49

Vernalis PLC23 May 2007 23 May 2007 VERNALIS PLC RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 MAY 2007 Vernalis plc announces that all resolutions proposed to shareholders at itsAnnual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votesreceived for each resolution is set out below. Resolution For (including Against* Withheld discretionary votes)*Ordinary Resolution1. To receive theaudited accounts and related reports of theDirectors and auditors 224,569,857 (99.99%) 10,707 (0.01%) 7,1572. To approve theremuneration report 217,328,467 (99.63%) 813,306 (0.37%) 6,445,9483. To re-elect as a Director Dr A Baxter 224,545,392 (99.99%) 33,176 (0.01%) 9,1534. To re-elect as a Director Ms C C Ferguson 224,544,267 (99.98%) 38,844 (0.02%) 4,6105. To re-elect asa Director Mr J AD Slater 224,553,615 (99.99%) 28,646 (0.01%) 5,4606. To elect as aDirector Mr I Clark 224,542,703 (99.98%) 35,049 (0.02%) 9,9697. To re-appointPricewaterhouseCoopers LLP as auditors and to authorise the Directors to determine their remuneration 223,611,362 (99.65%) 792,957 (0.35%) 183,4028. To authorise the Directors to allot relevantsecurities 224,537,200 (99.98%) 37,797 (0.02%) 12,724Special Resolution9. To authorise the Directors to allot equitysecurities for cash 224,527,782 (99.98%) 39,519 (0.02%) 20,420Ordinary Resolution10. To approve the Vernalis plc Bonus Long-TermIncentive Plan 199,330,753 (91.39%) 18,789,501 (8.61%) 6,467,467 *NB: Percentage of votes cast excludes withheld votes Enquiries: Vernalis plc +44 (0)118 977 3133Simon Sturge, Chief Executive OfficerTony Weir, Chief Financial Officer Brunswick Group +44 (0)20 7404 5959Jon ColesAlex Tweed This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Apr 20117:00 amRNSNotice of Results
16th Mar 20117:00 amRNSVernalis Initiates Phase I Trial of V158866
14th Mar 20117:00 amRNSAmericas Licensing Deal for tosedostat
28th Jan 20114:48 pmRNSHolding(s) in Company
21st Dec 20101:11 pmRNSHolding(s) in Company
16th Dec 20107:00 amRNSVernalis and H.Lundbeck A/S enter Collaboration
26th Nov 20104:40 pmRNSSecond Price Monitoring Extn
26th Nov 20104:35 pmRNSPrice Monitoring Extension
18th Nov 20107:00 amRNSInterim Management Statement
18th Nov 20107:00 amRNSVernalis plc: V3381 Programme Update
6th Oct 20107:00 amRNSVernalis and Servier Achieve Research Milestone
29th Jul 20107:00 amRNSInterim results for six months ended 30 June 2010
20th Jul 20104:44 pmRNSNotice of Interim Results
16th Jul 20107:00 amRNSPipeline update
29th Jun 20104:40 pmRNSSecond Price Monitoring Extn
29th Jun 20104:35 pmRNSPrice Monitoring Extension
9th Jun 20103:35 pmRNSHolding(s) in Company
7th Jun 20104:19 pmRNSHolding(s) in Company
4th Jun 20104:40 pmRNSSecond Price Monitoring Extn
4th Jun 20104:35 pmRNSPrice Monitoring Extension
3rd Jun 20103:22 pmRNSHolding(s) in Company
1st Jun 201012:32 pmRNSDirector/PDMR Shareholding
1st Jun 201012:26 pmRNSAGM Statement
19th May 20107:00 amRNSInterim Management Statement
17th May 20104:35 pmRNSPrice Monitoring Extension
4th May 20107:00 amRNSVernalis and Servier extend Oncology Collaboration
27th Apr 20105:16 pmRNSAnnual Information Update
27th Apr 20104:56 pmRNSAGM + Annual Report Notice
16th Apr 20101:17 pmRNSDirector/PDMR Shareholding
16th Apr 20101:16 pmRNSDirector/PDMR Shareholding
12th Apr 20107:00 amRNSAnnouncement of Results year ended 31 Dec 09
1st Apr 201010:30 amRNSNotice of Results
30th Mar 201012:56 pmRNSHolding(s) in Company
24th Mar 20107:00 amRNSIN-STEP Phase IIb study results
15th Mar 20107:00 amRNSVernalis earns milestone
8th Mar 20103:06 pmRNSVernalis Regains European Rights to Frovatriptan
5th Mar 20105:29 pmRNSHolding(s) in Company
5th Mar 20105:28 pmRNSHolding(s) in Company
5th Mar 20105:22 pmRNSHolding(s) in Company
2nd Mar 20105:49 pmRNSVoting Rights and Capital
1st Mar 201012:29 pmRNSResults of General Meeting
1st Mar 20107:00 amRNSPlacing & Open Offer Result
11th Feb 20104:20 pmRNSPublication of Prospectus
11th Feb 20107:00 amRNSPlacing and Open Offer
14th Dec 20097:00 amRNSVernalis announces clinical update
11th Dec 20097:00 amRNSVernalis Earns Milestone Payment
12th Nov 20097:00 amRNSInterim Management Statement
6th Oct 20094:40 pmRNSSecond Price Monitoring Extn
6th Oct 20094:35 pmRNSPrice Monitoring Extension
6th Oct 20097:00 amRNSInitiates Pilot Study of V3381 in Chronic Cough

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.